Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read456 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
Cotê D’Ivoire: Thousands Rally in Abidjan as Opposition Demands Electoral Reforms Ahead of October Election
Thousands of opposition supporters gathered in Abidjan on Saturday, May 31, to...
Togo Stops Issuing Mining Permits to Reform Outdated Mining Code
Togo has suspended the issuance of new mining permits for prospecting and...
ICYMI: Ghana Shuts Down Washington Embassy Over Visa Fraud Scandal
Ghana has temporarily closed its embassy in Washington, D.C., following the uncovering...
Confederation of Sahel States Moves to Establish Joint Judicial Body
The Confederation of Sahel States (CSS), comprising Mali, Niger, and Burkina Faso,...